Philip Leese is a Primary Care physician affiliated with IQVIA. OpenAlex indexes 65 publications with 3,481 citations (h-index 24); ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers
Sponsor: Marval Pharma Ltd.
- A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers
Sponsor: Tioga Pharmaceuticals
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Hassman, DO
Barbara Rizzardi, MD
Kimball Johnson, MD
Hessam Aazami, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”